Zobrazeno 1 - 10
of 62
pro vyhledávání: '"E. Vigevani"'
Autor:
F. Recchia, P. Marchei, R. Trevisonne, C. Pizza, S. Chiadò Cutin, M. Tonato, S. Del Prete, G. Vietti Ramus, C. Oliva, T. Iannone, Mario Roselli, V. Bortolussi, F. Nigro Imperiale, S. Venuta, V. Angelini, S. Cascinu, C. Volta, M. Musi, V. Guardasole, R. Ferraldeschi, L. Isa, Stefano Cascinu, F. Cognetti, M.L. Evangelista, E. Biondi, M.P. Sirgiovanni, C. Modenesi, V. Gebbia, D. Santini, E. Greco, E. Ferrazzi, M. Betti, F. Verderame, C. Bumma, G. Cicero, G. Pieri, G. Nastasi, A. Pessi, L. Patoia, S. Palazzo, M. Belli, C. Di Fonzo, Giuseppe Colucci, S. Cigolari, G. Fornarini, F. Ferraù, G. Rosati, A. Nuzzo, G. Porcile, P. Sozzi, A. Mozzicafreddo, M. Chetrì, B. Massidda, G. Luporini, A. Lembo, R. Carroccio, F. Testore, Enzo Ballatori, V. Bon-ciarelli, G. Ausili Cefaro, P. Marchetti, P. Berniolo, G. Filippelli, Enrico Cortesi, Salvatore Palazzo, A. Prosperi, G. Citone, M. Cremonesi, A. Peta, G. Rimondi, Giorgio Mustacchi, Francesco Di Costanzo, F. Marrocolo, R. Laricchiuta, R. Maurizi Enrici, D. Perrone, G. P. Iannello, Fausto Roila, A. Lavarello, L. Manzione, V. Lacava, G. Solina, P. Manente, A. Cioffi, R. Ceccherini, V. Sidoti, V. Picece, E. Recaldin, V. Tinessa, P. Giordani, M. D'Aprile, O. Bertetto, M. D'Amico, M. Serlenga, E. Vigevani, M. Mazzoli, Giovanni Mantovani, P. Marsilio, P. Rizzo, V. Mascia, G. Tonini, G. Carteni, Alberto Sobrero, B. Daniele, L. Milesi, Benedetta Ruggeri, G. Margutti, M. Botturi, M. Nicodemo, V. Silingardi, C. Iacono, A. Comandone, G. Colucci, P. Alessandroni, E. Zarra, G. Beretta, G. Reguzzoni, M. Turaz-za, L. Tonda, A. Rossi, G. Troccoli, S. Mosconi, G. Catalano, S. Bretti, T. Prantera, M. Destefanis, A. Sobrero, G. Cruciani, V. Sciacca, M. Marzola, P. Malacarne, M. Mandalà, L. Montalbetti, G. Tuveri, A Ruggiero, A. Zaniboni, G. Cetto, S. Spada, S. Barni, Roberto Labianca, C. Caroti, M.T. Ionta, C. Bressi
Publikováno v:
Tumori Journal. 91:472-476
Aims and Background Rarely are conclusions from clinical trials summarized in international consensus conferences and promptly transferred to patient care. The adjuvant therapy for colorectal cancer used in daily clinical practice in Italy is describ
Autor:
Giuseppe Cartei, A Buffoli, Giovanni Terrosu, Fabrizio Bresadola, C Sacco, A. Iop, Carla Cedolini, E. Vigevani, S Fongione, Alessandro Uzzau, Vittorio Bresadola, Umberto Baccarani, M. Signor
Publikováno v:
Diseases of the Esophagus. 16:9-16
Surgery with or without adjuvant radiotherapy (RT) is the standard treatment of esophageal cancer. Preoperative radio- and chemotherapy (CT) have been introduced to improve prognosis. We report a phase II prospective non-randomized trial of preoperat
Publikováno v:
Interventional Neuroradiology. 2:277-281
Twenty three patients (18 males) were followed from January 1993 to July 1996 for primary central nervous system malignancy: glioblastoma multiforme (GM) (15 patients), anaplastic astrocytoma (AA) (8 patients). Ninety one cycles (average 4 cycles per
Autor:
G. Tommasinp, M. Mansutti, A. Lavaronp, G. Cartei, A. Iop, Marco Leonardi, L. Clocchiatti, E. Vigevani, G. Vindignp, P.P. Janes, G. Fabris
Publikováno v:
Rivista di Neuroradiologia. 7:185-188
Autor:
E. Vigevani, Alberta Bergamo, G. Tabaro, F. Cartei, G. Salerno, M. Sanzari, L. Clocchiatti, Gianni Sava, P.G. Sala, G. Cartei
The synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr; TP-5) corresponding to the active site of the hormone thymopoietin, was given at the dose of 300 mg/m2/day (1 day), higher than the usually administered, to a group of 27 immunodepressed patients in or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7251c39c11f3f1eb4592ef3ab46466c5
https://hdl.handle.net/11368/2563847
https://hdl.handle.net/11368/2563847
Autor:
Angela Sibau, M. Mansutti, M. Giovannoni, Giuseppe Cartei, G. Clocchiatti, M. Signor, E. Vigevani
Publikováno v:
Cancer Treatment An Update ISBN: 9782817807676
Cancer of the ovary is the fifth cause of cancer death in women, and the majority of patients have advanced stage disease at the time of presentation [1]. Clinical responses can be achieve with current regimens in over half of patients but only a min
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::783b94c0325a5de102717394102f6ed3
https://doi.org/10.1007/978-2-8178-0765-2_97
https://doi.org/10.1007/978-2-8178-0765-2_97
Autor:
A, Geromin, M, Michieli, D, Damiani, A, Michelutti, E, Vigevani, M, Signor, R, Fanin, M, Baccarani
Publikováno v:
Haematologica. 77(6)
The multidrug resistance (MDR) associated 170kd glycoprotein (P170) is expressed at a low level in normal and malignant cells, but in the latter it becomes frequently overexpressed after chemotherapy. This study evaluated P170 expression in normal bl
Autor:
L, Clocchiatti, F, De Biasi, G, Cartei, A, Sibau, E, Vigevani, M, Signor, M, Giovannoni, V, Ceschia, F, Di Chiara, S, Grandis
Publikováno v:
Tumori. 77(5)
A prospective study was carried out on a recent marker for breast cancer, CA549, a mucine-like acid glycoprotein present in the fat membranes of human milk. Fifty healthy control subjects and 91 with benign conditions, 103 mammary cancer patients and
Autor:
Ornella Belvedere, A. Iop, Salvatore Tumolo, Cosimo Sacco, Gianpiero Fasola, E. Vigevani, L. Recchia, A. Sibau, Francesco Grossi, C. Rossetto
Publikováno v:
Journal of Clinical Oncology. 22:7363-7363
7363 Background: Two phase III trials have demonstrated an improvement in survival with docetaxel compared to other single-agents or best supportive care in previously treated NSCLC patients. Still...
Autor:
A. Lucenti, A. Iop, Giuseppe Cartei, M. Gusella, R. Talamini, V.M. De Pangher, G. Tabaro, Cosimo Sacco, E. Vigevani, Alessandra Bearz, A. Sibau
Publikováno v:
European Journal of Cancer. 37:S53